PRA acknowledges and thanks the members of the Rare Disease Advisory
Committee (RDAC) who provided their valuable contributions to the
development of these guidelines.
Exploring the Puzzling World of Rare Diseases
This week’s Industry Watch is covering better understanding of disease, from the relationship between COVID-19 and the gut - to the intersection of…
The True Cost of Ineffective Clinical Trials
The process of designing and implementing clinical trials hasn’t changed much over the decades — which may be why 1 in 5 clinical trials fail due to…